Literature DB >> 8267949

A review of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Fifth Report, 1993.

M H Alderman1.   

Abstract

JNC-V is a comprehensive document that also contains a variety of specific information about drug actions, interactions, and specific indications and contraindications for each class of antihypertensive drugs. In addition, there are recommendations regarding patient evaluation and follow-up. Individual sections deal with blood pressure management in special situations and in different populations. References are included to support the assertions made and to permit further assessment by the reader of some of the evidence that the committee used to reach its conclusions. In sum, the new Joint National Committee Report continues a tradition of bringing to the profession and the public at large the current best judgment regarding practice that is constantly in evolution. It is not the ultimate document, but another step toward a goal that remains the same. That goal is to reduce cardiovascular morbidity and mortality, improve and extend life, and to achieve these objectives in the least intrusive and most efficient way possible.

Entities:  

Mesh:

Year:  1993        PMID: 8267949     DOI: 10.1093/ajh/6.10.896

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  4 in total

1.  Heme oxygenase-1 promoter polymorphism is associated with risk of malignant mesothelioma.

Authors:  Aki Murakami; Yoshihiro Fujimori; Yoshie Yoshikawa; Shusai Yamada; Kunihiro Tamura; Noriko Hirayama; Takayuki Terada; Kozo Kuribayashi; Chiharu Tabata; Kazuya Fukuoka; Tomoko Tamaoki; Takashi Nakano
Journal:  Lung       Date:  2012-01-21       Impact factor: 2.584

2.  Association of low-moderate urine arsenic and QT interval: Cross-sectional and longitudinal evidence from the Strong Heart Study.

Authors:  Katherine A Moon; Yiyi Zhang; Eliseo Guallar; Kevin A Francesconi; Walter Goessler; Jason G Umans; Lyle G Best; Barbara V Howard; Richard B Devereux; Peter M Okin; Ana Navas-Acien
Journal:  Environ Pollut       Date:  2018-05-26       Impact factor: 8.071

Review 3.  Guidelines for the treatment of hypertension: a critical review.

Authors:  J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

4.  Low-moderate urine arsenic and biomarkers of thrombosis and inflammation in the Strong Heart Study.

Authors:  Katherine A Moon; Ana Navas-Acien; Maria Grau-Pérez; Kevin A Francesconi; Walter Goessler; Eliseo Guallar; Jason G Umans; Lyle G Best; Jonathan D Newman
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.